May 2002
Article Features
  White House Commission Reports on CAM
Making Post-Childbirth Treatment More Aggressive
Overcoming Constipation
Peer Counseling to Cope with Recovery
Detecting Cancer Earlier in High-Risk Women
Financial Assistance for Cancer Care
HRT Boosts Bone for up to 3 Years
Markers May Predict Benefit from Chemo
Predicting Metastasis in Small Breast Tumors
Pregnancy Weight Gain and Breast Cancer Risk
Sex Hormones May Raise Breast Cancer Risk
Confirming the Importance of Surgical Margins
Tamoxifen and Estrogen Have Similar Effects
Reducing Weight, Insulin and Cancer Risk
Detecting Early Breast and Ovarian Cancers in High-Risk Women


Complementry Articles
FDA Fast Tracks Arimidex to Treat Early Cancer
Combining Herceptin with Taxotere
"Protein Profiling" to Improve Cancer Therapy
St. John's Wort Reduces Chemo Effectiveness
A New TRAIL for Breast Cancer Treatment


Delays Between Breast Cancer Diagnosis and Treatment
Findings in a study published in the April 15, 2002, issue of the journal Cancer indicate that a delay of more than 20 weeks in diagnosing asymptomatic breast cancer-where a screening test first indicated a suspicious result-is associated with increasing tumor size and increasing risk of lymph node metastases.

Screening tests for breast cancer are useful because they can detect disease in women without symptoms. However, screening tests can also yield information that neither rules in nor rules out disease for the physician, leading to unnecessary and sometimes uncomfortable procedures in some women and long delays in diagnosis for others.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon